INOFLO EVOLVE DS

Serial Number 97934575
732

Registration Progress

Application Filed
May 12, 2023
Under Examination
Jan 2, 2024
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered

Attorney Assistance

Statement of Use Due - Extension 3 Granted
Due: Jan 02, 2026 178 days

Basic Information

Serial Number
97934575
Deadline
January 2, 2026
Description
Statement of Use or 4th Extension Due
Filing Date
May 12, 2023
Published for Opposition
November 7, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
732
Status Date
Jun 27, 2025
Application
Pending
Classes
005 010

Rights Holder

Mallinckrodt Pharmaceuticals Ireland Limited

99
Address
College Business & Technology Park
Cruiserath Road, Blanchardstown
Dublin 15 D15TX2V
IE

Ownership History

Mallinckrodt Pharmaceuticals Ireland Limited

Original Applicant
99
Dublin 15 IE

Mallinckrodt Pharmaceuticals Ireland Limited

Owner at Publication
99
Dublin 15 IE

Legal Representation

Attorney
Jeannine Rittenhouse

USPTO Deadlines

Next Deadline
178 days remaining
Statement of Use Due - Extension 3 Granted
Due Date
January 02, 2026
Extension Available
Until January 02, 2025

Application History

26 events
Date Code Type Description
Jun 28, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 27, 2025 EX3G S SOU EXTENSION 3 GRANTED
Jun 27, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 27, 2025 EXT3 S SOU EXTENSION 3 FILED
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 1, 2025 EX2G S SOU EXTENSION 2 GRANTED
Dec 31, 2024 EXT2 S SOU EXTENSION 2 FILED
Dec 31, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jul 1, 2024 EXT1 S SOU EXTENSION 1 FILED
Jul 1, 2024 EX1G S SOU EXTENSION 1 GRANTED
Jul 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 2, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 4, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 3, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 2, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 2, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2023 GNRT F NON-FINAL ACTION E-MAILED
Jul 14, 2023 CNRT R NON-FINAL ACTION WRITTEN
Jul 13, 2023 DOCK D ASSIGNED TO EXAMINER
Jun 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2023 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, nitric oxide for inhalation for treating pulmonary hypertension and conditions associated with pulmonary hypertension; Pharmaceutical preparations, namely, inhaled pharmaceutical preparations for treating pulmonary hypertension and conditions associated with pulmonary hypertension
Class 010
Medical apparatus and instruments for use in connection with the administration of gases to patients for medical and therapeutic purposes, namely, medical and therapeutic gas delivery systems comprised primarily of gas cylinders, valves, regulators, flow meters, delivery hoses and apparatus and instruments for setting, measuring and regulating the mixture of medical and therapeutic gases delivered to patients

Classification

International Classes
005 010